Profile Image
Sucha Nand Photo
Sucha Nand
Primary Department
Appointment Request
Request an Appointment
Blood Disorders
Cancers of the Blood and Blood Cells
Bone Marrow Disorders
Non-Hodgkin's Lymphoma
Clotting Disorder
Diagnosis of Bleeding or Clotting Disorders
Multiple Myeloma
Hodgkin's Lymphoma
Cardinal Bernardin Cancer Center
Medical Oncology, American Board of Internal Medicine Subspecialty
American Board of Internal Medicine
American Board of Internal Medicine Subspecialty Hematology
Medical School
Amritsar Medical College/Punjab University
Amritsar Medical College Hospital, Internal Medicine: General
Sir HN Hospital, Internal Medicine: General
VA Medical Center, North Chicago/Chicago Medical School, Internal Medicine: General
Northwestern University McGaw Medical Center, Internal Medicine: Hematology & Medical Oncology
Li,J.; Volk,A.; Zhang,J.; Cannova,J.; Dai,S.; Hao,C.; Hu,C.; Sun,J.; Xu,Y.; Wei,W.; Breslin,P.; Nand,S.; Chen,J.; Kini,A.; Zhu,J.; Zhang,J.Sensitizing leukemia stem cells to NF-kappaB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling Oncotarget 2017 ;8(5):8420-8435
Nand,S.Myeloproliferative Neoplasms The New England journal of medicine 2017 ;377(9):895
Berg,S.; Nand,S.Neurological Complications of the Leukemias Across the Ages Current neurology and neuroscience reports 2017 ;17(2):13-017-0726-1
Achille,N. J.; Othus,M.; Phelan,K.; Zhang,S.; Cooper,K.; Godwin,J. E.; Appelbaum,F. R.; Radich,J. P.; Erba,H. P.; Nand,S.; Zeleznik-Le,N. J.Association between early promoter-specific DNA methylation changes and outcome in older acute myeloid leukemia patients Leukemia research 2016 ;42:68-74
Othus,M.; van Putten,W.; Lowenberg,B.; Petersdorf,S. H.; Nand,S.; Erba,H.; Appelbaum,F.; Hills,R.; Russell,N.; Burnett,A.; Estey,E.Relationhip between event-free survival and overall survival in acute myeloid leukemia: A report from SWOG, HOVN/SAKK, and MRC/NCRI Haematologica 2016 ; :
Xin,J.; You,D.; Breslin,P.; Li,J.; Zhang,J.; Wei,W.; Cannova,J.; Volk,A.; Gutierrez,R.; Xiao,Y.; Ni,A.; Ng,G.; Schmidt,R.; Xia,Z.; Pan,J.; Chen,H.; Patel,M. M.; Kuo,P. C.; Nand,S.; Kini,A. R.; Zhang,J.; Chen,J.; Zhu,J.; Zhang,J.Sensitizing acute myeloid leukemia cells to induced differentiation by inhibiting the RIP1/RIP3 pathway Leukemia 2016 ; :
You,D.; Xin,J.; Volk,A.; Wei,W.; Schmidt,R.; Scurti,G.; Nand,S.; Breuer,E. K.; Kuo,P. C.; Breslin,P.; Kini,A. R.; Nishimura,M. I.; Zeleznik-Le,N. J.; Zhang,J.FAK Mediates a Compensatory Survival Signal Parallel to PI3K-AKT in PTEN-Null T-ALL Cells Cell reports 2015 ;10(12):2055-2068
Chen,H.; Li,Y.; Nand,S.; Quek,M. L.; Kini,A. R.; Barkan,G. A.Anaplastic large cell lymphoma involving the urinary bladder: a case report and review of the literature Diagnostic cytopathology 2015 ;43(1):60-65
Dublis,S.; Shah,S.; Nand,S.; Anderes,E.Anemias excluding cobalamin and folate deficiencies Handbook of clinical neurology 2014 ;120:1005-1014
Volk,A.; Li,J.; Xin,J.; You,D.; Zhang,J.; Liu,X.; Xiao,Y.; Breslin,P.; Li,Z.; Wei,W.; Schmidt,R.; Li,X.; Zhang,Z.; Kuo,P. C.; Nand,S.; Zhang,J.; Chen,J.; Zhang,J.Co-inhibition of NF-kappaB and JNK is synergistic in TNF-expressing human AML The Journal of experimental medicine 2014 ;211(6):1093-1108
Anderes,E.; Nand,S.Commonly used drugs in hematologic disorders Handbook of clinical neurology 2014 ;120:1125-1139
Nand,S.; Barton,K.; Schultz,R.; Klein,M.; Kini,A.Heckathorn disease revisited Blood 2014 ;123(9):1429-1431
Nand,S.; Othus,M.; Godwin,J. E.; Willman,C. L.; Norwood,T. H.; Howard,D. S.; Coutre,S. E.; Erba,H. P.; Appelbaum,F. R.A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia Blood 2013 ;122(20):3432-3439
Paner,A.; Jay,W. M.; Nand,S.; Michaelis,L. C.Cerebral Vein and Dural Venous Sinus Thrombosis: Risk Factors, Prognosis and Treatment—a Modern Approach Neuro-Ophthalmology 2009 ;33(5):237-247
Nand,S.; Godwin,J.; Smith,S.; Barton,K.; Michaelis,L.; Alkan,S.; Veerappan,R.; Rychlik,K.; Germano,E.; Stiff,P.Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trial Leukemia & lymphoma 2008 ;49(11):2141-2147
Portell,C.; Nand,S.Single agent lenalidomide induces a response in refractory T-cell posttransplantation lymphoproliferative disorder Blood 2008 ;111(8):4416-4417
Czerlanis,C.; Jay,W. M.; Nand,S.Inherited thrombophilia and the eye Seminars in ophthalmology 2008 ;23(2):111-119
Nand,S.; Barton,K.Blast crisis in chronic myelogenous leukemia remains a difficult therapeutic challenge Leukemia & lymphoma 2007 ;48(2):215-216
Adess,M.; Eisner,R.; Nand,S.; Godwin,J.; Messmore,H. L.,Jr; Wehrmacher,W. H.Thromboembolism in cancer patients: pathogenesis and treatment Clinical & Applied Thrombosis/Hemostasis 2006 ;12(3):254-266
Naeem,M.; Harrison,K.; Barton,K.; Nand,S.; Alkan,S.A unique case of acute promyelocytic leukemia showing monocytic differentiation after ATRA (all-trans retinoic acid) therapy. European journal of haematology 2006 ;76(2):164-166
Alkan,S.; Huang,Q.; Ergin,M.; Denning,M. F.; Nand,S.; Maududi,T.; Paner,G. P.; Ozpuyan,F.; Izban,K. F.Survival role of protein kinase C (PKC) in chronic lymphocytic leukemia and determination of isoform expression pattern and genes altered by PKC inhibition. American Journal of Hematology 2005 ;79(2):97-106
Houde,C.; Li,Y.; Song,L.; Barton,K.; Zhang,Q.; Godwin,J.; Nand,S.; Toor,A.; Alkan,S.; Smadja,N. V.; Avet-Loiseau,H.; Lima,C. S.; Miele,L.; Coignet,L. J.Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines. Blood 2004 ;104(12):3697-3704
Idilman,R.; Colantoni,A.; De Maria,N.; Alkan,S.; Nand,S.; Van Thiel,D. H.Lymphoproliferative disorders in chronic hepatitis C. Journal of viral hepatitis 2004 ;11(4):302-309
Hesketh,P. J.; Arena,F.; Patel,D.; Austin,M.; D'Avirro,P.; Rossi,G.; Colowick,A.; Schwartzberg,L.; Bertoli,L. F.; Cole,J. T.; Demetri,G.; Dessypris,E.; Dobbs,T.; Eisenberg,P.; Fleischman,R.; Hall,J.; Hoffman,P. C.; Laber,D. A.; Leonard,J.; Lester,E. P.; McCachren,S.; McMeekin,S.; Meza,L.; Miller,D. S.; Nand,S.; Oliff,I.; Paroly,W.; Pawl,L.; Perez,A.; Raftopoulos,H.; Rigas,J.; Rowland,K.; Scullin,D. C.,Jr; Tezcan,H.; Waples,J.; Ward,J.; Yee,L. K.A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignancies Cancer 2004 ;100(4):859-868
Tanvetyanon,T.; Nand,S.Herpes zoster during treatment with arsenic trioxide Annals of Hematology 2004 ;83(3):198-200
Tanvetyanon,T.; Nand,S.Pancytopenia in hereditary haemorrhagic telangiectasia. British journal of haematology 2004 ;127(4):371
Tanvetyanon,T.; Nand,S.Overcoming recurrent cutaneous reactions from imatinib using once-weekly dosing. Annals of Pharmacotherapy 2003 ;37(12):1818-1820
Kelly,N. P.; Alkan,S.; Nand,S.Hairy cell leukemia variant developing in a background of polycythemia vera Archives of Pathology & Laboratory Medicine 2003 ;127(4):e209-11
Pena,L. R.; Nand,S.; De Maria,N.; Van Thiel,D. H.Hepatitis C virus infection and lymphoproliferative disorders Digestive diseases and sciences 2000 ;45(9):1854-1860